Skip to main content
Top
Published in: Medical Microbiology and Immunology 3/2012

01-08-2012 | Original Investigation

Cytomegalovirus (CMV) seroprevalence in pregnant women, bone marrow donors and adolescents in Germany, 1996–2010

Authors: Gisela Enders, Anja Daiminger, Lisa Lindemann, Frank Knotek, Ursula Bäder, Simone Exler, Martin Enders

Published in: Medical Microbiology and Immunology | Issue 3/2012

Login to get access

Abstract

In Germany, studies on the IgG seroprevalence in pregnancy and in women of childbearing age are rare. Therefore, we retrospectively evaluated the CMV IgG seropositive rate in 40,324 pregnant women as well as in 31,093 female and male bone marrow donors over 15 consecutive years (1996–2010). Furthermore, the result of a study conducted in 1999 investigating 1,305 healthy adolescents with known ethnicity was included. The overall CMV IgG seroprevalence in pregnant women (15–50 years) was 42.3%. Age-dependent analysis revealed a significantly higher seropositive rate (55.6%) in young women (15–25 years) than in those aged 26–40 years (37–42%) and in women older than 40 years (48.3%). Over the study period of 15 years, the rate of seroprevalence in pregnant women declined significantly (χ2 test < 0.01) from 44.3% in the first interval period (1996–2000), to 42.8% (2001–2005) and to 40.9% (2006–2010). The most influencing factor on CMV seropositivity appeared to be the socioeconomic status (SES), which we characterized by type of health insurance: Seroprevalence in women with low, middle and upper SES was 91.8, 46.9 and 33.7%, respectively. Female bone marrow donors of childbearing age (15–45 years) showed a significantly higher seropositive rate of 36.5% than age-matched male donors (28.6%). In adolescents aged 13–16 years, no gender-specific differences were recognized. Concerning ethnicity, youngsters with German descent had a significantly lower seroprevalence (29.9%) than those with non-German descent (67.4%).
Literature
1.
go back to reference Stagno S, Pass FR, Cloud G, Britt EJ, Henderson RE, Walton PD, Veren DA, Page F, Alford CA (1986) Primary cytomegalovirus infection in pregnancy. Incidence, transmission to the fetus, and clinical outcome. JAMA 256:1904–1908PubMedCrossRef Stagno S, Pass FR, Cloud G, Britt EJ, Henderson RE, Walton PD, Veren DA, Page F, Alford CA (1986) Primary cytomegalovirus infection in pregnancy. Incidence, transmission to the fetus, and clinical outcome. JAMA 256:1904–1908PubMedCrossRef
2.
go back to reference Dollard SC, Grosse SD, Ross DS (2007) New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol 17(5):355–363PubMedCrossRef Dollard SC, Grosse SD, Ross DS (2007) New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol 17(5):355–363PubMedCrossRef
3.
go back to reference Fowler KB, Stagno S, Pass RF, Britt WJ, Boll TJ, Alford CA (1992) The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med 326(10):663–667PubMedCrossRef Fowler KB, Stagno S, Pass RF, Britt WJ, Boll TJ, Alford CA (1992) The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med 326(10):663–667PubMedCrossRef
4.
go back to reference Scholz H (2000) Häufigkeit der konnatalen Zytomegalie in der Bundesrepublik Deutschland. Monatsschr Kinderheilkd 148:887–890CrossRef Scholz H (2000) Häufigkeit der konnatalen Zytomegalie in der Bundesrepublik Deutschland. Monatsschr Kinderheilkd 148:887–890CrossRef
5.
go back to reference Hamprecht K, Abele H, Goelz R (2011) Tuebingen congenital CMV study: first epidemiological and diagnostic results. 13th International CMV/Betaherpesvirus workshop, Nuremberg, Germany Hamprecht K, Abele H, Goelz R (2011) Tuebingen congenital CMV study: first epidemiological and diagnostic results. 13th International CMV/Betaherpesvirus workshop, Nuremberg, Germany
6.
go back to reference Stratton K, Durch J, Lawrence R (2001) Vaccines for the 21st century: a tool for decicion-making. National Academy Press, Washington, DC Stratton K, Durch J, Lawrence R (2001) Vaccines for the 21st century: a tool for decicion-making. National Academy Press, Washington, DC
7.
go back to reference Pass RF (2009) Development and evidence for efficacy of CMV glycoprotein B vaccine with MF59 adjuvant. J Clin Virol 46:73–76CrossRef Pass RF (2009) Development and evidence for efficacy of CMV glycoprotein B vaccine with MF59 adjuvant. J Clin Virol 46:73–76CrossRef
8.
go back to reference Vauloup-Fellous C, Picone O, Cordier AG, Parent-du-Châtelet I, Senat MV, Frydman R, Grangeot-Keros L (2009) Does hygiene counseling have an impact on the rate of CMV primary infection during pregnancy? Results of a 3-year prospective study in a French hospital. J Clin Virol 46:49–53CrossRef Vauloup-Fellous C, Picone O, Cordier AG, Parent-du-Châtelet I, Senat MV, Frydman R, Grangeot-Keros L (2009) Does hygiene counseling have an impact on the rate of CMV primary infection during pregnancy? Results of a 3-year prospective study in a French hospital. J Clin Virol 46:49–53CrossRef
9.
go back to reference Enders G, Bäder U, Bartelt U et al (2003) Zytomegalievirus—(CMV-) Durchseuchung und Häufigkeit von CMV-Primärinfektionen bei schwangeren Frauen in Deutschland. Bundesgesundheitsbl—Gesundheitsforsch—Gesundheitsschutz 46:426–432 Enders G, Bäder U, Bartelt U et al (2003) Zytomegalievirus—(CMV-) Durchseuchung und Häufigkeit von CMV-Primärinfektionen bei schwangeren Frauen in Deutschland. Bundesgesundheitsbl—Gesundheitsforsch—Gesundheitsschutz 46:426–432
10.
go back to reference Cannon MJ, Schmid DS, Hyde TB (2010) Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol 20:202–213PubMedCrossRef Cannon MJ, Schmid DS, Hyde TB (2010) Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol 20:202–213PubMedCrossRef
11.
go back to reference Enders G (1985) Vergleich verschiedener Methoden zum Zytomegalieantikörpernachweis. In: Luthardt T (Ersg) Transfusionsbedingte Zytomegalievirusinfectionen, Steinkopff, Darmstadt, pp 53–67 Enders G (1985) Vergleich verschiedener Methoden zum Zytomegalieantikörpernachweis. In: Luthardt T (Ersg) Transfusionsbedingte Zytomegalievirusinfectionen, Steinkopff, Darmstadt, pp 53–67
12.
go back to reference Enders G (1986) Diagnosis of cytomegalovirus infection. In Simon C, Wilkinson P (eds) Diagnosis of infectious diseases—new aspects, 1st edn. Schattauer, Stuttgart, pp 225–235 Enders G (1986) Diagnosis of cytomegalovirus infection. In Simon C, Wilkinson P (eds) Diagnosis of infectious diseases—new aspects, 1st edn. Schattauer, Stuttgart, pp 225–235
13.
go back to reference Lübeck PR, Doerr HW, Rabenau HF (2010) Epidemiology of human cytomegalovirus (HCMV) in an urban region of Germany: what has changed? Med Microbiol Immunol 199(1):53–60PubMedCrossRef Lübeck PR, Doerr HW, Rabenau HF (2010) Epidemiology of human cytomegalovirus (HCMV) in an urban region of Germany: what has changed? Med Microbiol Immunol 199(1):53–60PubMedCrossRef
14.
go back to reference Just-Nübling G, Korn S, Ludwig B, Stephan C, Doerr HW, Preiser W (2003) Primary cytomegalovirus infection in an outpatient setting—laboratory markers and clinical aspects. Infection 31(5):318–323PubMed Just-Nübling G, Korn S, Ludwig B, Stephan C, Doerr HW, Preiser W (2003) Primary cytomegalovirus infection in an outpatient setting—laboratory markers and clinical aspects. Infection 31(5):318–323PubMed
15.
go back to reference Halwachs-Baumann G, Genser B (2003) Prävalenz von CMV IgG bei Schwangeren im Einzugsgebiet LKH/Universitätsklinikum Graz. In: Halwachs-Baumann G, Genser B (eds) Die konnatale Zytomegalievirusinfektion, 1st edn. Springer, Wien, pp 43–44CrossRef Halwachs-Baumann G, Genser B (2003) Prävalenz von CMV IgG bei Schwangeren im Einzugsgebiet LKH/Universitätsklinikum Graz. In: Halwachs-Baumann G, Genser B (eds) Die konnatale Zytomegalievirusinfektion, 1st edn. Springer, Wien, pp 43–44CrossRef
16.
go back to reference Hecker M, Qiu D, Marquardt K, Bein G, Hackstein H (2004) Continuous cytomegalovirus seroconversion in a large group of healthy blood donors. Vox Sang 86(1):41–44PubMedCrossRef Hecker M, Qiu D, Marquardt K, Bein G, Hackstein H (2004) Continuous cytomegalovirus seroconversion in a large group of healthy blood donors. Vox Sang 86(1):41–44PubMedCrossRef
17.
go back to reference Friese K, Beichert M, Hof H et al (1991) Incidence of congenital infections. Geburtshilfe Frauenheilkunde 51:890–896CrossRef Friese K, Beichert M, Hof H et al (1991) Incidence of congenital infections. Geburtshilfe Frauenheilkunde 51:890–896CrossRef
18.
go back to reference Tookey PA, Ades AE, Peckham CS (1992) Cytomegalovirus prevalence in pregnant women: the influence of parity. Arch Dis Childh 67:779–783PubMedCrossRef Tookey PA, Ades AE, Peckham CS (1992) Cytomegalovirus prevalence in pregnant women: the influence of parity. Arch Dis Childh 67:779–783PubMedCrossRef
19.
go back to reference Gambarotto K, Ranger-Rogez S, Aubard Y, Piver P, Duffetelle B, Delpeyroux C, Roussanne MC, Nicot T, Denis F (1997) Primary cytomegalovirus infection and pregnant women: epidemiological study on 1100 women at Limoges. Pathol Biol (Paris) 45(6):453–461 Gambarotto K, Ranger-Rogez S, Aubard Y, Piver P, Duffetelle B, Delpeyroux C, Roussanne MC, Nicot T, Denis F (1997) Primary cytomegalovirus infection and pregnant women: epidemiological study on 1100 women at Limoges. Pathol Biol (Paris) 45(6):453–461
20.
go back to reference Gratacap-Cavallier B, Bosson JL, Morand P, Dutertre N, Chanzy B, Jouk PS, Vandekerckhove C, Cart-Lamy P, Seigneurin JM (1998) Cytomegalovirus seroprevalence in French pregnant women: parity and place of birth as major predictive factors. Eur J Epidemiol 14:147–152PubMedCrossRef Gratacap-Cavallier B, Bosson JL, Morand P, Dutertre N, Chanzy B, Jouk PS, Vandekerckhove C, Cart-Lamy P, Seigneurin JM (1998) Cytomegalovirus seroprevalence in French pregnant women: parity and place of birth as major predictive factors. Eur J Epidemiol 14:147–152PubMedCrossRef
21.
go back to reference de Mattia D, Stroffolini T, Arista S, Pistoia D, Giammanco A, Maggio M, Chiaramonte M, Moschen ME, Mura I, Rigo G et al (1991) Prevalence of cytomegalovirus infection in Italy. Epidemiol Infect 107(2):421–427PubMedCrossRef de Mattia D, Stroffolini T, Arista S, Pistoia D, Giammanco A, Maggio M, Chiaramonte M, Moschen ME, Mura I, Rigo G et al (1991) Prevalence of cytomegalovirus infection in Italy. Epidemiol Infect 107(2):421–427PubMedCrossRef
22.
go back to reference de Ory F, Ramírez R, García Comas L, León P, Sagües MJ, Sanz JC (2004) Is there a change in cytomegalovirus seroepidemiology in Spain? Eur J Epidemiol 19(1):85–89PubMedCrossRef de Ory F, Ramírez R, García Comas L, León P, Sagües MJ, Sanz JC (2004) Is there a change in cytomegalovirus seroepidemiology in Spain? Eur J Epidemiol 19(1):85–89PubMedCrossRef
23.
go back to reference Bate SL, Dollard SC, Cannon MJ (2010) Cytomegalovirus seroprevalence in the United States: the national health and nutrition examination surveys, 1988–2004. Clin Infect Dis 50(11):1439–1447PubMedCrossRef Bate SL, Dollard SC, Cannon MJ (2010) Cytomegalovirus seroprevalence in the United States: the national health and nutrition examination surveys, 1988–2004. Clin Infect Dis 50(11):1439–1447PubMedCrossRef
24.
go back to reference Eskild A, Jenum PA, Bruu AL (2005) Maternal antibodies against cytomegalovirus in pregnancy and the risk of fetal death and low birth weight. Acta Obstet Gynecol Scand 84:1035–1041PubMed Eskild A, Jenum PA, Bruu AL (2005) Maternal antibodies against cytomegalovirus in pregnancy and the risk of fetal death and low birth weight. Acta Obstet Gynecol Scand 84:1035–1041PubMed
25.
go back to reference Knowles SJ, Grundy K, Cahill I, Cafferkey MT, Geary M (2005) Low cytomegalovirus sero-prevalence in Irish pregnant women. Ir Med J 98:210–212PubMed Knowles SJ, Grundy K, Cahill I, Cafferkey MT, Geary M (2005) Low cytomegalovirus sero-prevalence in Irish pregnant women. Ir Med J 98:210–212PubMed
26.
go back to reference Gaytant MA, Galama JM, Semmekrot BA, Melchers WJ, Sporken JM, Oosterbaan HP, van Dop PA, Huisman A, Merkus HM, Steegers EA (2005) The incidence of congenital cytomegalovirus infections in The Netherlands. J Med Virol 76:71–75PubMedCrossRef Gaytant MA, Galama JM, Semmekrot BA, Melchers WJ, Sporken JM, Oosterbaan HP, van Dop PA, Huisman A, Merkus HM, Steegers EA (2005) The incidence of congenital cytomegalovirus infections in The Netherlands. J Med Virol 76:71–75PubMedCrossRef
27.
go back to reference Mustakangas P, Sarna S, Ämmäiä P, Muttilainen M, Koskela P, Koskiniemi M (2000) Human cytomegalovirus seroprevalence in three socioeconomically different urban areas during the first trimester: a population-based cohort study. Int J Epidemiol 29:587–591PubMedCrossRef Mustakangas P, Sarna S, Ämmäiä P, Muttilainen M, Koskela P, Koskiniemi M (2000) Human cytomegalovirus seroprevalence in three socioeconomically different urban areas during the first trimester: a population-based cohort study. Int J Epidemiol 29:587–591PubMedCrossRef
28.
go back to reference Statistical Office For the Federal Republic of Germany, Wiesbaden; www-genesis.destatis.de Statistical Office For the Federal Republic of Germany, Wiesbaden; www-genesis.destatis.de
29.
go back to reference Ocak S, Zeteroglu S, Ozer C, Dolapcioglu K, Gungoren A (2007) Seroprevalence of Toxoplasma gondii, rubella and cytomegalovirus among pregnant women in southern Turkey. Scand J Infect Dis 39(3):231–234PubMedCrossRef Ocak S, Zeteroglu S, Ozer C, Dolapcioglu K, Gungoren A (2007) Seroprevalence of Toxoplasma gondii, rubella and cytomegalovirus among pregnant women in southern Turkey. Scand J Infect Dis 39(3):231–234PubMedCrossRef
30.
go back to reference Tamer GS, Dundar D, Caliskan E (2009) Seroprevalence of Toxoplasma gondii, rubella and cytomegalovirus among pregnant women in western region of Turkey. Clin Invest Med 32(1):E43–E47PubMed Tamer GS, Dundar D, Caliskan E (2009) Seroprevalence of Toxoplasma gondii, rubella and cytomegalovirus among pregnant women in western region of Turkey. Clin Invest Med 32(1):E43–E47PubMed
31.
go back to reference Federal Statistical Office Wiesbaden; Statistical Yearbook (2011) For the Federal Republic of Germany Federal Statistical Office Wiesbaden; Statistical Yearbook (2011) For the Federal Republic of Germany
32.
go back to reference Adler SP (1991) Cytomegalovirus and child day care: risk factors for maternal infection. Pediatr Infect Dis J 10(8):590–594PubMedCrossRef Adler SP (1991) Cytomegalovirus and child day care: risk factors for maternal infection. Pediatr Infect Dis J 10(8):590–594PubMedCrossRef
33.
go back to reference Adler SP, Finney JW, Manganello AM, Best AM (2004) Prevention of child-to-mother transmission of cytomegalovirus among pregnant women. J Pediatr 145:485–491PubMedCrossRef Adler SP, Finney JW, Manganello AM, Best AM (2004) Prevention of child-to-mother transmission of cytomegalovirus among pregnant women. J Pediatr 145:485–491PubMedCrossRef
34.
go back to reference Enders G (2003) Infektionsgefährdung: Mutterschutz im Krankenhaus—eine Übersicht. Arbeitsmed Sozialmed Umweltmed 38:324–335 Enders G (2003) Infektionsgefährdung: Mutterschutz im Krankenhaus—eine Übersicht. Arbeitsmed Sozialmed Umweltmed 38:324–335
35.
go back to reference Enders G (2006) Labormedizinische Aspekte bei Cytomegalie und Toxoplasmose. gynäkologie + geburtshilfe 1:24–28 Enders G (2006) Labormedizinische Aspekte bei Cytomegalie und Toxoplasmose. gynäkologie + geburtshilfe 1:24–28
36.
go back to reference Nigro G, Adler SP, La Torre R, Best AM (2005) Congenital Cytomegalovirus Collaborating Group. Passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med 353:1350–1362PubMedCrossRef Nigro G, Adler SP, La Torre R, Best AM (2005) Congenital Cytomegalovirus Collaborating Group. Passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med 353:1350–1362PubMedCrossRef
37.
go back to reference Jacquemard F, Yamamoto M, Costa JM, Romand S, Jaqz-Aigrain E, Dejean A, Daffos F, Ville Y (2007) Maternal administration of valaciclovir in symptomatic intrauterine cytomegalovirus infection. BJOG 114(9):1113–1121PubMedCrossRef Jacquemard F, Yamamoto M, Costa JM, Romand S, Jaqz-Aigrain E, Dejean A, Daffos F, Ville Y (2007) Maternal administration of valaciclovir in symptomatic intrauterine cytomegalovirus infection. BJOG 114(9):1113–1121PubMedCrossRef
38.
go back to reference Engman ML, Malm G, Engstrom L, Petersson K, Karltorp E, Tear Fahnehjelm K, Uhlen I, Guthenberg C, Lewensohn-Fuchs I (2008) Congenital CMV infection: prevalence in newborns and the impact on hearing deficit. Scand J Infect Dis 40(11–12):935–942PubMedCrossRef Engman ML, Malm G, Engstrom L, Petersson K, Karltorp E, Tear Fahnehjelm K, Uhlen I, Guthenberg C, Lewensohn-Fuchs I (2008) Congenital CMV infection: prevalence in newborns and the impact on hearing deficit. Scand J Infect Dis 40(11–12):935–942PubMedCrossRef
39.
go back to reference Alanen A, Kahala K, Vahlberg T, Koskela P, Vainionpää R (2005) Seroprevalence, incidence of prenatal infections and reliability of maternal history of varicella zoster virus, cytomegalovirus, herpes simplex virus and parvovirus B19 infection in South-Western Finland. BJOG 12(1):50–56 Alanen A, Kahala K, Vahlberg T, Koskela P, Vainionpää R (2005) Seroprevalence, incidence of prenatal infections and reliability of maternal history of varicella zoster virus, cytomegalovirus, herpes simplex virus and parvovirus B19 infection in South-Western Finland. BJOG 12(1):50–56
Metadata
Title
Cytomegalovirus (CMV) seroprevalence in pregnant women, bone marrow donors and adolescents in Germany, 1996–2010
Authors
Gisela Enders
Anja Daiminger
Lisa Lindemann
Frank Knotek
Ursula Bäder
Simone Exler
Martin Enders
Publication date
01-08-2012
Publisher
Springer-Verlag
Published in
Medical Microbiology and Immunology / Issue 3/2012
Print ISSN: 0300-8584
Electronic ISSN: 1432-1831
DOI
https://doi.org/10.1007/s00430-012-0232-7

Other articles of this Issue 3/2012

Medical Microbiology and Immunology 3/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.